Business OpportunitiesHC notice to Ranbaxy founding members over property row
The Delhi High Court today issued notices to Ranbaxy founding family members - Manjit Singh, Nimmi Singh, Malvinder Mohan Singh and Shivender Mohan Singh in a property dispute with Max India Group Chairman Analjit Singh.
- Ranbaxy to launch Daiichi"s drug in Africa - Outsourcing steroid for Indian pharma firms - As molecule deals fall, pharma firms see cure in late licensing - HC orders status quo on properties of Ranbaxy"s ex-patriarch - Ranbaxy to launch generic version of Flomax next year - Fortis in talks to buy Lanka hospital chain
A Division Bench comprising Justice Vikramjit Sen and Justice Sunil Gaur issued the notices on a petition filed by Analjit Singh.
The court has directed them to file their replies by February 25, the next date of hearing.
Analjit Singh has challenged an order passed by a single-member Bench last month that had dismissed his plea claiming that the will of late Bhai Mohan Singh is not binding on them.
He had also alleged his brother Manjit Singh had made "false and misleading" statement regarding a family settlement and ownership of the 15, Aurangzeb Road property here.
However, Justice S Ravindra Bhatt did not agree with his submission and said there was no dispute over the execution of their family settlement of 1987.
Challenging it, the Max India Group Chairman had submitted before the Division Bench that the single judge had not considered his plea which was necessary to decide the controversy between the parties.